Pharmaceutical Company · Gurgaon, Haryana
Pfizer Limited India, the publicly-listed Indian subsidiary of Pfizer Inc. (USA), one of the world’s largest research-based pharmaceutical companies, manages its India corporate functions from Gurgaon, Haryana. Pfizer India has been operating in India since 1950 and has manufacturing facilities in Goa and Mumbai, while the Gurgaon office handles commercial, regulatory, and medical affairs for the Indian market.
Pfizer India’s product portfolio spans multiple therapeutic areas including anti-infectives (Zithromax, Magnex, Pencom), cardiovascular (Caduet, Norvasc), neuroscience (Lyrica, Relpax), oncology (Ibrance, Xalkori, Inlyta), inflammation & immunology (Xeljanz), and vaccines (Prevnar 13/20 for pneumococcal disease, COMIRNATY for COVID-19). Pfizer is also a leader in hospital injectable antibiotics and oncology biosimilars.
Pfizer has a strong track record of regulatory approvals in India and maintains significant manufacturing and commercial infrastructure. The Gurgaon office coordinates Pfizer’s significant portfolio of innovative patented and off-patent branded medicines across India.
Company: Pfizer Limited India
Location: Gurgaon (Gurugram), Haryana
Business Type: Global Pharmaceutical Subsidiary – Multi-Therapeutic Innovative Medicines
No products found.